保和丸联合阿卡波糖对糖耐量异常的肥胖者血清铁蛋白水平的影响

Effects of Baohewan Combined With Acarbose Serum Ferritin Levels of Abnormal Obesity on Glucose Tolerance

目的 探讨保和丸与阿卡波糖联合使用对糖耐量异常的肥胖者血清铁蛋白水平和其他指标的影响.方法 将本院自2009年4月~2012年4月收入的154例糖耐量异常的肥胖患者分为对照组和观察组,对照组患者单独使用阿卡波糖而观察组将保和丸和阿卡波糖联合使用进行治疗.连续治疗24周,观察两组患者血清铁蛋白水平以及其他指标的变化.结果 两组患者体重指数、血清铁蛋白水平、空腹血糖、葡糖糖负荷后2h血糖、血脂在治疗前、后差异均有统计性意义,观察组的指标变化更明显.（P〈0.0 1 或〈0.0 5）.结论 保和丸联合阿卡波糖治疗糖耐量异常的肥胖症患者,可以更好的降低患者血清铁蛋白水平,增加糖耐量,减少糖尿病风险.

Objective To investigate the combined modality therapy effect of Baohe Wan and acarbose on patients with impaired glucose tolerance and Obesity serum ferritin levels. Methods 154 cases of glucose tolerance and obesity serum ferritin levels were divided into the observation group and the control group, tThe patients in the control group were treated with acarbose, and the the observation group treated with both Baohe Wan and acarbose for a course of 24 months. Results the level of Body mass index, Serum ferritin,fasting Ploma gloucose, 2h oral glucose-tolerance test of the two group had significant different, and the observation group had more different. Conclusion The combined modality therapy of Baobe Wan and acarbose have effectt on decrease the level of serum ferritin and ncrease the glucose tolerance and reduced risk of diabetes.